ADA Scientific Sessions 2025 Abstract

Effects of Switching Glucagon-Like Peptide 1 Receptor Agonists on HbA1c, Body Weight, and Treatment Satisfaction among Patients with Type 2 Diabetes—A Meta-analysis

By Xinyan Jia, Pengfei Liu, Yufu Liu, Zhenqiang Song

ReviewInterventions

The paper

Xinyan Jia, Pengfei Liu, Yufu Liu, Zhenqiang Song

Tianjin

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, late-breaking 1994-LB

doi.org/10.2337/db25-1994-lb

Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs